{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:39:16Z","timestamp":1792118356699,"version":"4.4.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.clbc.2021.01.006","type":"journal-article","created":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T03:07:30Z","timestamp":1614049650000},"page":"e539-e546","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Microablative Fractional CO2 Laser for Vulvovaginal Atrophy in Women With a History of Breast Cancer: A Pilot Study at 4-week Follow-up"],"prefix":"10.1016","volume":"21","author":[{"given":"Stefano","family":"Salvatore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella E.","family":"Nappi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1249-308X","authenticated-orcid":false,"given":"Arianna","family":"Casiraghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9983-523X","authenticated-orcid":false,"given":"Alessandro F.","family":"Ruffolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Degliuomini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Parma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Leone Roberti Maggiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavros","family":"Athanasiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Candiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2021.01.006_bib1","series-title":"Cancer Facts and Figures\u00a02014","year":"2014"},{"key":"10.1016\/j.clbc.2021.01.006_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/tbj.12361","article-title":"Milestones in breast cancer treatment","volume":"21","author":"Zurrida","year":"2015","journal-title":"Breast J"},{"key":"10.1016\/j.clbc.2021.01.006_bib3","series-title":"From cancer patient to cancer survivor: lost in transition","year":"2006"},{"key":"10.1016\/j.clbc.2021.01.006_bib4","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1002\/cncr.25106","article-title":"Incidence and time course of bleeding after long-term amenorrhea after breast cancer treatment: a prospective study","volume":"116","author":"Sukumvanich","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2021.01.006_bib5","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/jnci\/djr541","article-title":"Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review","volume":"104","author":"Howard-Anderson","year":"2012","journal-title":"J\u00a0Natl Can Inst"},{"key":"10.1016\/j.clbc.2021.01.006_bib6","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1524-4741.2009.00766.x","article-title":"Quality of life after breast cancer: survivorship and sexuality","volume":"15","author":"Dizon","year":"2009","journal-title":"Breast J"},{"key":"10.1016\/j.clbc.2021.01.006_bib7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4065\/mcp.2009.0413","article-title":"Vulvovaginal atrophy","volume":"85","author":"Mac Bride","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clbc.2021.01.006_bib8","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1200\/JCO.2009.23.1274","article-title":"Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen","volume":"28","author":"Dowsett","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2021.01.006_bib9","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/GME.0000000000000401","article-title":"Histological study on the effectiveness of microablative fractional CO2 laser on atrophic vaginal tissue: an ex\u00a0vivo study","volume":"22","author":"Salvatore","year":"2015","journal-title":"Menopause"},{"key":"10.1016\/j.clbc.2021.01.006_bib10","doi-asserted-by":"crossref","first-page":"e0230681","DOI":"10.1371\/journal.pone.0230681","article-title":"Quality of life and psychological functioning in postmenopausal women undergoing aromatase inhibitor treatment for early breast cancer","volume":"15","author":"Martino","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.clbc.2021.01.006_bib11","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/13697137.2012.657589","article-title":"The use of hormone therapy for the maintenance of urogynecological and sexual health post WHI","volume":"15","author":"Nappi","year":"2012","journal-title":"Climacteric"},{"key":"10.1016\/j.clbc.2021.01.006_bib12","doi-asserted-by":"crossref","first-page":"345","DOI":"10.23736\/S0026-4784.19.04469-1","article-title":"Joint recommendations for the diagnosis and treatment of vulvo-vaginal atrophy in women in the peri- and post-menopausal phases from the Societ\u00e0 Italiana per la Menopausa (SIM) and the Societ\u00e0 Italiana della Terza Et\u00e0 (SIGiTE)","volume":"71","author":"Cagnacci","year":"2019","journal-title":"Minerva Ginecol"},{"key":"10.1016\/j.clbc.2021.01.006_bib13","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.clbc.2015.06.005","article-title":"Genitourinary syndrome of menopause in breast cancer survivors: are we facing new and safe hopes?","volume":"15","author":"Biglia","year":"2015","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.clbc.2021.01.006_bib14","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3109\/13697137.2014.899347","article-title":"A\u00a012-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study","volume":"17","author":"Salvatore","year":"2014","journal-title":"Climacteric"},{"key":"10.1016\/j.clbc.2021.01.006_bib15","doi-asserted-by":"crossref","first-page":"150","DOI":"10.5301\/je.5000184","article-title":"Microablative fractional CO2 laser improves dyspareunia related to vulvovaginal atrophy: a pilot study","volume":"6","author":"Salvatore","year":"2014","journal-title":"J\u00a0Endometriosis Pelvic Pain Dis"},{"key":"10.1016\/j.clbc.2021.01.006_bib16","first-page":"1","article-title":"Fractional CO2 laser improves sexual function in women with vulvovaginal atrophy","author":"Salvatore","year":"2014","journal-title":"Climacteric"},{"key":"10.1016\/j.clbc.2021.01.006_bib17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/GME.0000000000001428","article-title":"Efficacy of fractional CO2 laser treatment in postmenopausal women with genitourinary syndrome: a multicenter study","volume":"27","author":"Filippini","year":"2020","journal-title":"Menopause"},{"key":"10.1016\/j.clbc.2021.01.006_bib18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0002-9378(96)70243-0","article-title":"The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction","volume":"175","author":"Bump","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clbc.2021.01.006_bib19","first-page":"3","article-title":"Long-term non-hormonal treatment of vaginal dryness","volume":"8","author":"Bachmann","year":"1992","journal-title":"Clin Pract Sexuality"},{"key":"10.1016\/j.clbc.2021.01.006_bib20","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","article-title":"A\u00a012-item short-form health survey: construction of scales and preliminary tests of reliability and validity","volume":"34","author":"Ware","year":"1996","journal-title":"Med Care"},{"key":"10.1016\/j.clbc.2021.01.006_bib21","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/978-3-642-45769-2_38","article-title":"Impact of different adjuvant therapy strategies on quality of life in breast cancer survivors","volume":"152","author":"Ganz","year":"1998","journal-title":"Recent Results Cancer Res"},{"key":"10.1016\/j.clbc.2021.01.006_bib22","doi-asserted-by":"crossref","first-page":"26.e1","DOI":"10.1016\/j.ajog.2010.08.035","article-title":"Urogenital disorders in women with adjuvant endocrine therapy after early breast cancer","volume":"204","author":"Baumgart","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clbc.2021.01.006_bib23","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0140-6736(12)61963-1","article-title":"Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial","volume":"381","author":"Davies","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.clbc.2021.01.006_bib24","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/jnci\/dji071","article-title":"Menopausal hormone therapy after breast cancer: the Stockholm randomized trial","volume":"97","author":"Von Schoultz","year":"2005","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2021.01.006_bib25","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejca.2012.07.003","article-title":"Hormone replacement therapy after breast cancer: 10-year follow up of the Stockholm randomised trial","volume":"49","author":"Fahlen","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clbc.2021.01.006_bib26","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/AOG.0b013e3182118790","article-title":"Vaginal pH-balanced gel for the control of atrophic vaginitis among breast cancer survivors: a randomized controlled trial","volume":"117","author":"Lee","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clbc.2021.01.006_bib27","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1097\/AOG.0000000000000283","article-title":"Locating pain in breast cancer survivors experiencing dyspareunia: a randomized controlled trial","volume":"123","author":"Goetsch","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clbc.2021.01.006_bib28","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/gme.0b013e318279ba64","article-title":"Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy","volume":"20","author":"Portman","year":"2013","journal-title":"Menopause"},{"key":"10.1016\/j.clbc.2021.01.006_bib29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.maturitas.2014.02.015","article-title":"Ospemifene, a non-oestrogen selective oestrogen receptor modulator for the treatment of vaginal dryness associated with postmenopausal vulvar and vaginal atrophy: a randomised, placebo-controlled, phase III trial","volume":"78","author":"Portman","year":"2014","journal-title":"Maturitas"},{"key":"10.1016\/j.clbc.2021.01.006_bib30","doi-asserted-by":"crossref","first-page":"R881","DOI":"10.1186\/bcr1317","article-title":"Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ","volume":"7","author":"Namba","year":"2005","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.clbc.2021.01.006_bib31","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0960-0760(01)00066-8","article-title":"In\u00a0vitro and in\u00a0vivo biologic effects of ospemifene (FC-1271a) in breast cancer","volume":"77","author":"Taras","year":"2001","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.clbc.2021.01.006_bib32","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jsbmb.2005.06.027","article-title":"Ospemifene inhibits the growth of dimethylbenzanthracene-induced mammary tumors in Sencar mice","volume":"97","author":"Wurz","year":"2005","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.clbc.2021.01.006_bib33","doi-asserted-by":"crossref","first-page":"e556","DOI":"10.1016\/j.clbc.2019.04.007","article-title":"The impact of vaginal laser treatment for genitourinary syndrome of menopause in breast cancer survivors: a systematic review and meta-analysis","volume":"19","author":"Jha","year":"2019","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.clbc.2021.01.006_bib34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10549-019-05384-9","article-title":"Vaginal CO2 laser for the treatment of vulvo-vaginal atrophy in women with breast cancer: LAAVA pilot study","volume":"178","author":"Pearson","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2021.01.006_bib35","first-page":"3669","article-title":"Fractional Co2 laser therapy for genitourinary syndrome of menopause for breast cancer survivors","volume":"28","author":"Quick","year":"2020","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.clbc.2021.01.006_bib36","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00404-016-4118-6","article-title":"Fractional CO2 laser for vulvovaginal atrophy (VVA) dyspareunia relief in breast cancer survivors","volume":"294","author":"Pieralli","year":"2016","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.clbc.2021.01.006_bib37","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/GME.0000000000001206","article-title":"Microablative fractional CO2 laser for the genitourinary syndrome of menopause: up to 12-month results","volume":"26","author":"Athanasiou","year":"2019","journal-title":"Menopause"},{"key":"10.1016\/j.clbc.2021.01.006_bib38","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/GME.0000000000001416","article-title":"A\u00a0randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: The VeLVET Trial","volume":"27","author":"Paraiso","year":"2020","journal-title":"Menopause"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820921000070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820921000070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:23:45Z","timestamp":1761513825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820921000070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S1526820921000070"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2021.01.006","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microablative Fractional CO2 Laser for Vulvovaginal Atrophy in Women With a History of Breast Cancer: A Pilot Study at 4-week Follow-up","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2021.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}